Antimicrobial Resistance results in more than 700,000 deaths annually.
The United Nations predict this figure to rise to 10 million deaths annually by 2050.
AusDiagnostics is supporting Antimicrobial Awareness Week in 2021. Find out more about AMR and how we can assist you in performing AMR surveillance below.
Systems included in the Ultraplex Alliance™ and Highplex Alliance™ and TandemPlex® Panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, and the European Economic Area and is included on the Australian Register of Therapeutic Goods (ARTG), and compliant with the European IVD Directive 98/79/EC. Research use only in USA.